De Facto Communications - Lab Insights

Healthcare PR

Knowledge contributions

'2022: pharma targets nutraceutical products' image

Management January 14 2022

2022: pharma targets nutraceutical products

January 14 2022

'High manufacturing demand will lead to constraints' image

Management January 6 2022

High manufacturing demand will lead to constraints

'WuXi STA Passes the First U.S. FDA Inspection' image

Quality January 5 2022

WuXi STA Passes the First U.S. FDA Inspection

'Emmes Acquires Institut Dr. Schauerte' image

Management January 5 2022

Emmes Acquires Institut Dr. Schauerte

'Hoth Therapeutics Sign API and Drug Product Contracts with WuXi STA' image

R&D December 13 2021

Hoth Therapeutics Sign API and Drug Product Contracts with WuXi STA

December 13 2021

'ATMPS and Assurea LLC launch strategic collaboration' image

R&D December 10 2021

ATMPS and Assurea LLC launch strategic collaboration

December 10 2021

'Emmes Announces Completion of Third ACTT Clinical Trial for COVID-19' image

Quality December 2 2021

Emmes Announces Completion of Third ACTT Clinical Trial for COVID-19

December 2 2021

'WuXi STA Forms Strategic Partnership with Coherent Biopharma' image

Management December 2 2021

WuXi STA Forms Strategic Partnership with Coherent Biopharma

December 2 2021

'Medinfar awarded' image

Management November 29 2021

Medinfar awarded

November 29 2021

Contact

Get in touch with De Facto Communications

Info

a.allsop@defacto.com
02037358168